CompletedNot Applicable

Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language

France30 participantsStarted 2018-11-14

Plain-language summary

Mastocytosis is a heterogeneous rare disease. A 27-item questionnaire to assess the quality of life of patients with cutaneous/ indolent systemic mastocytosis was developed in the German language and validated in the English language in 2015. The team of the University Charité Berlin and the company Moxie - intellectual proprietor of the questionnaire - proposed the use of the recommendations of Baiardini et al. 2010, for linguistic adaptation of this questionnaire in other languages.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult, native French patient with cutaneous or indolent systemic mastocytosis and follow-up at CEREMAST, Toulouse * Patient having given his agreement of non-opposition Exclusion Criteria: * Minor patient * Patient with other forms of mast cell pathology except cutaneous and / or indolent systemic mastocytosis * Patient with no mast cell pathology * French non-native patient * Patient in detention or under guardianship * Patient not affiliated with Social Security

What they're measuring

The understanding of aspects of the questionnaire Mc-QoL

Timeframe: 1 day

The understanding of aspects of the questionnaire Mc-QoL

Timeframe: 1 day

The understanding of aspects of the questionnaire Mc-QoL

Timeframe: 1 day

The understanding of aspects of the questionnaire Mc-QoL

Timeframe: 1 day

Trial details

NCT IDNCT03632811

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-11-21

View on ClinicalTrials.gov More Cutaneous Mastocytosis trials